A
Albion Finch Medical Centre | Clinical Practice of Family Medicine
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BI 456906
BI 685509
Linagliptin
Maridebart Cafraglutide
Sugar
Lebrikizumab
NN0519-0130
Glimepiride
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 9 total trials
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems